Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|3|342-358

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.3, 2011-01, pp. : 342-358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: The Development of Novel Inhibitors for the Treatment of HIV Infection)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1765-1766

Bentham Science Publishers

Access to resources Recommend Favorite

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

By Buckheit Robert W  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1423-1442

Informa Healthcare

Access to resources Recommend Favorite

Combination Nucleoside/Nucleotide Reverse Transcriptase Inhibitors for Treatment of HIV Infection

By Akanbi Maxwell O   Scarsi Kimberly   Taiwo Babafemi   Murphy Robert L  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 65-79

Informa Healthcare

Access to resources Recommend Favorite

CDK inhibitors in clinical development for the treatment of cancer

By Fischer Peter M   Gianella-Borradori Athos  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 955-970

Informa Healthcare

Access to resources Recommend Favorite

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie   Barreiro Pablo   Vincent Vincent  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite